Litcius/Paper detail

The beneficial effects of <i>Ganoderma lucidum</i> on cardiovascular and metabolic disease risk

Sze Wa Chan, Brian Tomlinson, Paul Chan, Christopher Wai Kei Lam

2021Pharmaceutical Biology60 citationsDOIOpen Access PDF

Abstract

CONTEXT: (Curtis) P. Karst. (Ganodermataceae), also known as Lingzhi, has received considerable attention for various indications, including some related to the prevention and treatment of cardiovascular and metabolic disease by ameliorating major cardiovascular risk factors. OBJECTIVE: in relation to the main risk factors for cardiometabolic disease. METHODS: , Lingzhi, Reishi, cardiovascular, hypoglycaemic, diabetes, dyslipidaemia, antihypertensive, and anti-inflammatory. RESULTS: possesses antioxidative, antihypertensive, hypoglycaemic, lipid-lowering, and anti-inflammatory properties, but the health benefits in clinical trials are inconsistent. Among these potential health benefits, the most compelling evidence thus far is its hypoglycaemic effects in patients with type 2 diabetes or hyperglycaemia. CONCLUSIONS: preparations standardised by known active components in the prevention and treatment of cardiometabolic disease.

Topics & Concepts

Ganoderma lucidumDiseaseMedicineTraditional medicineContext (archaeology)Metabolic syndromePioglitazonePharmacologyDiabetes mellitusInternal medicineType 2 diabetesBiologyEndocrinologyPaleontologyFungal Biology and ApplicationsAntioxidants, Aging, Portulaca oleraceaMedicinal Plants and Bioactive Compounds